Evidence map›Paper›PMID 33178579›Full record

ArticleFrontiers in oncology2020

Hepatocarcinoma Induces a Tumor Necrosis Factor-Dependent Kupffer Cell Death Pathway That Favors Its Proliferation Upon Partial Hepatectomy.

Jean-François Hastir, Sandrine Delbauve, Lionel Larbanoix, Desislava Germanova, Cleo Goyvaerts, Justine Allard, Sophie Laurent, Karine Breckpot, Alain Beschin, Martin Guilliams and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jean-François HastirInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
Sandrine DelbauveInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
Lionel LarbanoixCenter for Microscopy and Molecular Imaging, Université de Mons, Brussels, Belgium.
Desislava GermanovaInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
Cleo GoyvaertsLaboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.
Justine AllardDiapath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles, Brussels, Belgium.
Sophie LaurentCenter for Microscopy and Molecular Imaging, Université de Mons, Brussels, Belgium.
Karine BreckpotLaboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.
Alain BeschinLaboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Martin GuilliamsLaboratory of Myeloid Cell Ontogeny and Functional Specialization, VIB Center for Inflammation Research, Ghent, Belgium.
Véronique FlamandInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium.
Université Libre de Bruxelles · BEVrije Universiteit Brussel · BEUniversity of Mons · BEVIB-UGent Center for Inflammation Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Partial hepatectomy (PH) is the main treatment for early-stage hepatocellular carcinoma (HCC). Yet, a significant number of patients undergo recursion of the disease that could be linked to the fate of innate immune cells during the liver regeneration process. In this study, using a murine model, we investigated the impact of PH on HCC development by bioluminescence imaging and flow cytometry. While non-resected mice were able to control and reject orthotopic implanted Hepa1-6 hepatocarcinoma cells, resected liver underwent an increased tumoral proliferation. This phenomenon was associated with a PH-induced reduction in the number of liver-resident macrophages, i.e., Kupffer cells (KC). Using a conditional ablation model, KC were proved to participate in Hepa1-6 rejection. We demonstrated that in the absence of Hepa1-6, PH-induced KC number reduction was dependent on tumor necrosis factor-alpha (TNF-α), receptor-interacting protein kinase (RIPK) 3, and caspase-8 activation, whereas interleukin (IL)-6 acted as a KC pro-survival signal. In mice with previous Hepa1-6 encounter, the KC reduction switched toward a TNF-α-RIPK3-caspase-1 activation. Moreover, KC disappearance associated with caspase-1 activity induced the recruitment of monocyte-derived cells that are beneficial for tumor growth, while caspase-8-dependent reduction did not. In conclusion, our study highlights the importance of the TNF-α-dependent death pathway induced in liver macrophages following partial hepatectomy in regulating the antitumoral immune responses.

Indexed as

cell deathhepatocellular carcinomainflammationKupffer cellsliver regenerationpartial hepatectomytumor necrosis factor-alpha

Identifiers

PMID33178579
PMCPMC7597592
OpenAlexW3093185007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.